华海药业取得一项药品注册证书

Core Viewpoint - Huahai Pharmaceutical (600521.SH) has received approval from the National Medical Products Administration for the drug registration certificate of Trimebutine Maleate Tablets, which are intended to improve symptoms related to gastrointestinal motility disorders [1] Group 1 - The approved drug, Trimebutine Maleate Tablets, is used for the treatment of symptoms such as loss of appetite, nausea, vomiting, belching, abdominal distension, borborygmi, abdominal pain, diarrhea, and constipation [1] - The medication is also indicated for the management of Irritable Bowel Syndrome (IBS) [1]